Boehringer-Lilly-Yuhan marketing cooperation for ‘Jardiance’

Published: 2016-04-28 10:43:03

Updated: 2016-04-28 10:43:03

When it came to the launch of ‘Jardiance,’ an SGLT-2 inhibitor antidiabetic, Boehringer Ingelheim Korea, Lilly Korea and Yuhan Corporation announced a joint marketing/sales plan.

The 3 companies held a ceremony to firm cooperation of marketing and sales activities on the 25^th, having the launch of Jardiance, a new type 2 antidiabetic, ahead.

Through strategic alliances and cooperation start...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.